Cargando…
Pharmacokinetics of Tobramycin Administered at the Beginning of Intermittent Hemodialysis Session (ESRD Study)
BACKGROUND AND OBJECTIVES: There is a renewed interest in the successful use of aminoglycosides due to increasing resistance in gram-negative infections. Few studies to date have examined the pharmacokinetics (PK) of intradialytic infusions of tobramycin. This study sought to characterize the pharma...
Autores principales: | Giroux, Marjolaine, Bouchard, Nicolas, Henderson, Anik, Lam, Lesly, Tran, Van Anh Sylvie, Projean, Denis, Tessier, Jean-François, Lepage, Laurence, Gavra, Paul, Ouellet, Georges, Vallée, Michel, Lafrance, Jean-Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897820/ https://www.ncbi.nlm.nih.gov/pubmed/33680482 http://dx.doi.org/10.1177/2054358120987061 |
Ejemplares similares
-
Experience With Pre-Dialysis Administration of Tobramycin in the Outpatient Setting
por: Tessier, Jean-François, et al.
Publicado: (2022) -
High mortality after pelvis and lower limb fractures in ESRD
por: Ouellet, Georges, et al.
Publicado: (2008) -
Tobramycin administered by the TOBI(®) Podhaler(®) for persons with cystic fibrosis: a review
por: VanDevanter, Donald R, et al.
Publicado: (2011) -
ODP626 Weekend Hypoglycemia: A Case of Intermittent Endogenous Hyperinsulinemic Hypoglycemia Caused by Prolonged Interval Between Hemodialysis Sessions in ESRD
por: Mitchell, Ashley, et al.
Publicado: (2022) -
Single-Bolus Tinzaparin Anticoagulation in Extended Hemodialysis Session: A Feasibility Study
por: Harvey, Benoît, et al.
Publicado: (2023)